Our genomes provide the instructions for proper growth and development. Millions of genomic switches, known as enhancers, control the location and timing of gene expression, which in turn ensures the correct proteins are made in the right cells at the right time throughout our lives.
Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 01.10.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed